Tolerability of long-term temperature controlled whole-body thermal treatment in advanced cancer-bearing dogs

References

• Jha S, Sharma PK, Malviya R. Hyperthermia: role and risk factor for cancer treatment. Achiev Life Sci. 2016;10(2):161–167.
   Google Scholar
• Kok HP, Cressman ENK, Ceelen W, et al. Heating technology for malignant tumors: a review [internet]. Int J Hyperthermia. 2020;37(1):711–741.
   PubMed Web of Science ®Google Scholar
• Jia D, Liu J. Current devices for high-performance whole-body hyperthermia therapy. Expert Rev Med Devices. 2010;7(3):407–423.
   PubMed Web of Science ®Google Scholar
• Lee SY, Fiorentini G, Szasz AM, et al. Quo vadis oncological hyperthermia (2020)? frontiers in oncology. Frontiers Media S.A. 2020;10:1690.
   Google Scholar
• Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43(1):33–56. Elsevier;
   PubMed Web of Science ®Google Scholar
• Dieing A, Ahlers O, Hildebrandt B, et al. The effect of induced hyperthermia on the immune system. Prog Brain Res. 2007;2007:137–152.
   Google Scholar
• Sherar M, Liu FF, Pintilie M, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys. 1997;39(2):371–380.
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23(13):3079–3085.
   PubMed Web of Science ®Google Scholar
• Baronzio GF, della SR, D’Amico M, et al. Effects of local and whole body hyperthermia on immunity. 2013; [cited 2021 Mar 4]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK6083/.
   Google Scholar
• Oei AL, Kok HP, Oei SB, et al. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Adv Drug Delivery Rev. 2020;163–164:84–97.
   PubMed Web of Science ®Google Scholar
• Kerner T, Hildebrandt B, Ahlers O, et al. Anaesthesiological experiences with whole body hyperthermia. Int J Hyperthermia. 2003 [cited 2021 Feb 2;19(1):1–12.
   PubMed Web of Science ®Google Scholar
• Kraybill WG, Olenki T, Evans SS, et al. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models. Int J Hyperthermia. 2002;18(3):253–266.
   PubMed Web of Science ®Google Scholar
• Gordon I, Paoloni M, Mazcko C, et al. The comparative oncology trials consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Med. 2009;6(10):e1000161.
   PubMed Web of Science ®Google Scholar
• Park JS, Withers SS, Modiano JF, et al. Canine cancer immunotherapy studies: linking mouse and human. j Immunotherapy Cancer. 2016;4(1):7.
   Google Scholar
• Macy DW, Macy CA, Scott RJ, et al. Physiological studies of whole-body hyperthermia of Dogs1. Cancer Res. 1985;45(6):2769–2773.
   PubMed Web of Science ®Google Scholar
• Page RL, Meyer RE, Thrall DE, et al. Cardiovascular and metabolic response of tumour-bearing dogs to whole body hyperthermia. Int J Hyperthermia. 1987;3(6):513–525.
   PubMed Web of Science ®Google Scholar
• Meyer RE, Page RL, Thrall DE, et al. Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia. Cancer Res. 1986;46(11):5599–5601.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Page RL, Mcleod DA. Use of insulation to reduce extremity temperature nonuniformity during whole body hyperthermia in Dogs1. Cancer Research. 1987;47(22):5880–5882.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Page RL, Dewhirst MW, et al. Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia. Cancer Res. 1986;46(12 Pt 1):6229–6235.
   PubMed Web of Science ®Google Scholar
• Page RL, Mcentee MC, Williams PL, et al. Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs. Int J Hyperthermia. 1994;10(6):807–816.
   PubMed Web of Science ®Google Scholar
• Riviere JE, Page RL, Dewhirst M, et al. Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. Int J Hyperthermia. 1986;2(4):351–358.
   PubMedGoogle Scholar
• Novotney CA, Page RL, Macy DW, et al. Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. J Vet Intern Med. 1992;6(4):245–249.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Prescott DM, Samulski T. V, et al. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. Int J Radiat Oncol Biol Phys. 1996;34(5):1087–1096.
   PubMed Web of Science ®Google Scholar
• Gillette SM, Dawson CA, Scott RJ, et al. Whole-body hyperthermia combined with hyperfractionated irradiation of the thorax in dog: acute physiological response. Int J Hyperthermia. 1993;9(3):369–382.
   PubMed Web of Science ®Google Scholar
• Page RL, Macy DW, Ogilvie GK, et al. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. Int J Hyperthermia. 1992;8(2):187–197.
   PubMed Web of Science ®Google Scholar
• Hauck ML, Price GS, Ogilvie GK, et al. Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma. Int J Hyperthermia. 1996;12(3):309–320.
   PubMed Web of Science ®Google Scholar
• Carneiro MW, Brancato L, Wylleman B, et al. Safety evaluation of long-term temperature controlled whole-body thermal treatment in female aachen minipig. Int J Hyperthermia. 2021;38(1):165–175.
   PubMed Web of Science ®Google Scholar
• Lavalle GE, de Campos CB, Bertagnolli AC, et al. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. In Vivo. 2012;26(3):375–379.
   PubMed Web of Science ®Google Scholar
• Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1. 2011.
   Google Scholar
• Summers C, Rankin SM, Condliffe AM, et al. Neutrophil kinetics in health and disease [internet]. Trends in Immunology. 2010;31(8):318–324.
   PubMed Web of Science ®Google Scholar
• Mozzini C, Xotta G, Garbin U, et al. Non-exertional heatstroke: a case report and review of the literature. Am J Case Rep. 2017;18:1058–1065.
   Google Scholar
• Diehl KA, Crawford E, Shinko PD, et al. Alterations in hemostasis associated with hyperthermia in a canine model. J. Hematol. 2000;64(4):262–270.
   Web of Science ®Google Scholar
• Lassche G, Frenzel T, Mignot MH, et al. Thermal distribution, physiological effects and toxicities of extracorporeally induced whole-body hyperthermia in a pig model. Physiol Rep. 2020;8(4):366.
   Web of Science ®Google Scholar
• Porter A, Rozanski E, Price LL, et al. Article evaluation of cardiac troponin I in dogs presenting to the emergency room using a point-of-care assay. Can Vet J. 2016;57(6):641–645.
   PubMed Web of Science ®Google Scholar
• Baker P, Leckie T, Harrington D, et al. Exercise-induced cardiac troponin elevation: an update on the evidence, mechanism and implications. IJC Heart Vasculature. 2019;22:181–186.
   PubMed Web of Science ®Google Scholar
• Wakshlag JJ, Kraus MS, Gelzer AR, et al. The influence of High-Intensity moderate duration exercise on cardiac troponin I and C-Reactive protein in sled dogs. J Vet Intern Med. 2010;24(6):1388–1392.
   PubMed Web of Science ®Google Scholar